Dr Kari Nadeau, one of the nation’s foremost experts in adult and paediatric allergy, leads translational research and clinical studies at Packard Children’s, and directs the Nadeau Laboratory at Stanford. Her medical research and clinical practice, in addition to her accomplishments in drug development in the biotech industry, have given her the tools to manage the complex web of food allergy research.
Dr Nadeau studies the mechanisms involved in food allergies to better understand how to prevent and cure the disease. She has led many clinical research studies of food allergic disorders. She is currently running studies in oral immunotherapy for multiple food allergies, with very promising results, as well as four clinical studies in eosinophilic esophagitis (EoE).
Dr Nadeau’s work has been recognized with numerous grants and awards, and her research is part of a prestigious Clinical and Translational Science Award from the national Institutes of Health (NIH). As a member of a national network of leading allergy researchers, Dr. Nadeau collaborates with colleagues at University of North Carolina, University of Arkansas, Harvard (Children's Boston), Johns Hopkins, Univeristy of Pennsylvania, Northwestern University, and Mt Sinai. She also frequently presents at national and international meetings to share her findings and to exchange ideas with colleagues from around the globe.